4d Molecular Therapeutics In shares owned by Lazard Asset Management
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $0 | 26 | 0.00 |
| 2024-06-30 | $0 | 90 | 0.00 |
| 2024-03-31 | $40k | 1.5k | 26.32 |
| 2023-12-31 | $192k | 9.5k | 20.22 |
| 2023-09-30 | $0 | 2.3k | 0.00 |
| 2023-06-30 | $0 | 2.2k | 0.00 |
| 2023-03-31 | $0 | 1.5k | 0.00 |
| 2022-12-31 | $43k | 2.2k | 19.61 |